226 related articles for article (PubMed ID: 25185423)
1. The prognostic values of GDF-15 in comparison with NT-proBNP in patients with normotensive acute pulmonary embolism.
Duran L; Kayhan S; Guzel A; Ince M; Kati C; Akdemir HU; Yavuz Y; Zengin H; Okuyucu A; Murat N
Clin Lab; 2014; 60(8):1365-71. PubMed ID: 25185423
[TBL] [Abstract][Full Text] [Related]
2. Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism.
Lankeit M; Jiménez D; Kostrubiec M; Dellas C; Kuhnert K; Hasenfuß G; Pruszczyk P; Konstantinides S
Eur Respir J; 2014 Jun; 43(6):1669-77. PubMed ID: 24627529
[TBL] [Abstract][Full Text] [Related]
3. Growth differentiation factor-15 combined with N-terminal prohormone of brain natriuretic peptide increase 1-year prognosis prediction value for patients with acute heart failure: a prospective cohort study.
Hao J; Cheang I; Zhang L; Wang K; Wang HM; Wu QY; Zhou YL; Zhou F; Xu DJ; Zhang HF; Yao WM; Li XL
Chin Med J (Engl); 2019 Oct; 132(19):2278-2285. PubMed ID: 31567379
[TBL] [Abstract][Full Text] [Related]
4. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein in acute pulmonary embolism.
Abul Y; Karakurt S; Ozben B; Toprak A; Celikel T
J Investig Med; 2011 Jan; 59(1):8-14. PubMed ID: 21218608
[TBL] [Abstract][Full Text] [Related]
6. [NT-proBNP for risk stratification of pulmonary embolism].
Dores H; Fonseca C; Leal S; Rosário I; Abecasis J; Monge J; Correia MJ; Bronze L; Leitão A; Arroja I; Aleixo A; Silva A
Rev Port Cardiol; 2011 Dec; 30(12):881-6. PubMed ID: 22100750
[TBL] [Abstract][Full Text] [Related]
7. Combined risk stratification with computerized tomography /echocardiography and biomarkers in patients with normotensive pulmonary embolism.
Ozsu S; Karaman K; Mentese A; Ozsu A; Karahan SC; Durmus I; Oztuna F; Kosucu P; Bulbul Y; Ozlu T
Thromb Res; 2010 Dec; 126(6):486-92. PubMed ID: 20920821
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of N-terminal-proBNP in differentiating acute pulmonary embolism from heart failure in patients with acute dyspnea.
Guo L; Li G; Wang Y; Liang H; Shan X; Zhang N; Wang M; Lin D; Zhu L
Chin Med J (Engl); 2014; 127(16):2888-93. PubMed ID: 25131222
[TBL] [Abstract][Full Text] [Related]
9. Additional Diagnostic Value of Growth Differentiation Factor-15 (GDF-15) to N-Terminal B-Type Natriuretic Peptide (NT-proBNP) in Patients with Different Stages of Heart Failure.
Li J; Cui Y; Huang A; Li Q; Jia W; Liu K; Qi X
Med Sci Monit; 2018 Jul; 24():4992-4999. PubMed ID: 30019695
[TBL] [Abstract][Full Text] [Related]
10. Midregional proadrenomedullin (MR-proADM) in the risk stratification of patients with acute pulmonary embolism.
Pedowska-Włoszek J; Kostrubiec M; Kurnicka K; Ciurzynski M; Palczewski P; Pruszczyk P
Thromb Res; 2013 Nov; 132(5):506-10. PubMed ID: 24060192
[TBL] [Abstract][Full Text] [Related]
11. No firm association between N-terminal pro-brain natriuretic peptide and percentage of pulmonary vascular obstruction in patients with acute pulmonary embolism.
Agterof MJ; Schutgens RE; Verzijlbergen JF; van Buul MM; Tromp EA; Eijkemans MJ; van der Griend R; Biesma DH
Thromb Res; 2011 Jun; 127(6):547-50. PubMed ID: 21421260
[TBL] [Abstract][Full Text] [Related]
12. Comparison of PESI, echocardiogram, CTPA, and NT-proBNP as risk stratification tools in patients with acute pulmonary embolism.
Vamsidhar A; Rajasekhar D; Vanajakshamma V; Lakshmi AY; Latheef K; Siva Sankara C; Obul Reddy G
Indian Heart J; 2017; 69(1):68-74. PubMed ID: 28228310
[TBL] [Abstract][Full Text] [Related]
13. Cardiac biomarkers and clinical scores for risk stratification in elderly patients with non-high-risk pulmonary embolism.
Vuilleumier N; Limacher A; Méan M; Choffat J; Lescuyer P; Bounameaux H; Aujesky D; Righini M
J Intern Med; 2015 Jun; 277(6):707-16. PubMed ID: 25285747
[TBL] [Abstract][Full Text] [Related]
14. Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism.
Lankeit M; Kempf T; Dellas C; Cuny M; Tapken H; Peter T; Olschewski M; Konstantinides S; Wollert KC
Am J Respir Crit Care Med; 2008 May; 177(9):1018-25. PubMed ID: 18263797
[TBL] [Abstract][Full Text] [Related]
15. Comparing the effect of cardiac biomarkers on the outcome of normotensive patients with acute pulmonary embolism.
Jenab Y; Pourjafari M; Sotoudeh M; Lotfi-Tokaldany M; Etesamifard N; Shirani S; Jalali A; Nozari Y; Poorhosseini HR
Monaldi Arch Chest Dis; 2017 May; 87(1):767. PubMed ID: 28635193
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
[TBL] [Abstract][Full Text] [Related]
17. The N-terminal pro-brain-type natriuretic peptide based short-term prognosis in patients with acute pulmonary embolism according to renal function.
Berghaus TM; Behr W; von Scheidt W; Schwaiblmair M
J Thromb Thrombolysis; 2012 Jan; 33(1):58-63. PubMed ID: 22033585
[TBL] [Abstract][Full Text] [Related]
18. N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism.
Pruszczyk P; Kostrubiec M; Bochowicz A; Styczyński G; Szulc M; Kurzyna M; Fijałkowska A; Kuch-Wocial A; Chlewicka I; Torbicki A
Eur Respir J; 2003 Oct; 22(4):649-53. PubMed ID: 14582919
[TBL] [Abstract][Full Text] [Related]
19. Soluble neprilysin, NT-proBNP, and growth differentiation factor-15 as biomarkers for heart failure in dialysis patients (SONGBIRD).
Claus R; Berliner D; Bavendiek U; Vodovar N; Lichtinghagen R; David S; Patecki M; Launay JM; Bauersachs J; Haller H; Hiss M; Balzer MS
Clin Res Cardiol; 2020 Aug; 109(8):1035-1047. PubMed ID: 32002632
[TBL] [Abstract][Full Text] [Related]
20. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension.
Rhodes CJ; Wharton J; Howard LS; Gibbs JS; Wilkins MR
Heart; 2011 Jul; 97(13):1054-60. PubMed ID: 21558476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
